Revance Therapeutics, Inc.
(NASDAQ: RVNC)
Settlement
Claim Deadline: August 28, 2026 (25 Days Left)
Settlement Fund: $17,000,000
Settlement Class
All persons or entities that purchased or acquired Revance Securities (defined below) during the period of February 29, 2024 through the close of the subject Merger on February 6, 2025, inclusive (the “Class Period”), including common stock (CUSIP: 761330109; ticker “RVNC”) and 1.75% fixed coupon Convertible Senior Unsecured Notes (CUSIP: 761330AB5).
Settlement Status
Preliminarily Approved
Class Period
February 29, 2024 - February 28, 2025
Hearing Date
August 10, 2026
Claim Deadline
August 28, 2026
Documents
Settlement Website
revancesecuritiessettlement.com/home/Claims Admin
A.B. Data, Ltd.
P.O. Box 173120 Milwaukee, WI 53217
+1 877-507-1390
info@RevanceSecuritiesSettlement.comLevi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.